SentinelOne (S) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

PTC Therapeutics (PTCT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Bio-Techne faces significant macro and policy headwinds, including reduced academic research funding, China risks, and U.S.

With the stock's current price at Rs 1617.00, Blue Star's performance reflects a combination of positive price movement and ...

On stocks to buy on Thursday, Osho Krishan of Angel One recommended two stocks - One 97 Communications Ltd (Paytm), and ...

Discover the ITC Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a top-performing ...

Investors remain cautious in anticipation of the ECB's interest rate announcements - GEK TERNA rallies after the placement of ...

Poland’s election of a Trump-backed conservative nationalist president early this week is part of a larger shift to the right across the European continent: Much like in the US, conservative, ...

Recent trading activity from some of Wall Street's most-followed investors shows a clear pattern between some of the hottest ...